The Parkinson's disease (PD)-causative leucine-rich repeat kinase 2 (LRRK2) belongs to the Roco family of G-proteins comprising a Ras-of-complex (Roc) domain followed by a C-terminal of Roc (COR) domain in tandem (called Roc-COR domain). Two prokaryotic Roc-COR domains have been characterized as 'G proteins activated by guanine nucleotide-dependent dimerization' (GADs), which require dimerization for activation of their GTPase activity and bind guanine nucleotides with relatively low affinities. Additionally, LRRK2 Roc domain in isolation binds guanine nucleotides with relatively low affinities. As such, LRRK2 GTPase domain was predicted to be a GAD. Herein, we describe the design and high-level expression of human LRRK2 Roc-COR domain (LRRK2 Roc-COR). Biochemical analyses of LRRK2 Roc-COR reveal that it forms homodimers, with the C-terminal portion of COR mediating its dimerization. Furthermore, it co-purifies and binds Mg 2+ GTP/GDP at 1 : 1 stoichiometry, and it hydrolyzes GTP with K m and k cat of 22 nM and 4.70 9 10 À4 min
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Abbreviations used: ArfGAP1, ADP-ribosylation factor GTPase-activating protein 1; C. tepidum, Chlorobium tepidum; COR, C-terminal of Roc; GAP, GTPase-activating protein; GEF, guanine nucleotide exchange factor; LRRK2, leucine-rich repeat kinase 2; M. barkeri, Methanosarcina barkeri; predicted domains: an N-terminal armadillo repeat domain, an ankyrin repeat domain, a LRR domain, a Ras-like GTPase domain (Roc, Ras of complex proteins), a C-terminal of Roc (COR) domain, a protein kinase domain, and a WD-40 repeat domain (Mata et al. 2006; Mills et al. 2014) . The arrangement of LRR, Roc, COR, and kinase domains is typical of Roco family proteins, found in eukaryotic and prokaryotic species (Bosgraaf and Van Haastert 2003; Marin et al. 2008) . All Roco family members contain a Roc domain followed by a C-terminal COR domain (Bosgraaf and Van Haastert 2003; Marin et al. 2008) . Structural and biochemical analyses of two prokaryotic Roco proteins revealed that the Roc and COR domains form extensive inter-domain interactions to govern dimerization and catalytic properties of their GTPase activity (Gotthardt et al. 2008; Terheyden et al. 2015) . As such, the Roc and COR domains are considered to act as a single functional unit, which is referred to as the Roc-COR tandem domain. Dysregulation of the Roc GTPase domain of LRRK2 is implicated in PD pathogenesis because of the prevalent PD-causative R1441C/G/H mutations mapped to this domain; these mutations lead to decreased GTPase activity (Paisan-Ruiz et al. 2004; Floris et al. 2009; Matta et al. 2012) . In addition to altering GTPase activity, the R1441H mutation also perturbs the thermal stability of the LRRK2 Roc domain when bound to guanine nucleotides or their analogs (Li et al. 2009; Liao et al. 2014) . Emerging evidence suggests that the Roc domain may be central to LRRK2 function, possibly exerting a regulatory influence on the kinase domain [reviewed in (Terheyden et al. 2016) ]. LRRK2 forms homodimers in cells, and purified recombinant full-length LRRK2 forms dimers in solution (Klein et al. 2009; Civiero et al. 2012; Guaitoli et al. 2016; Sejwal et al. 2017) . Furthermore, LRRK2 is known to form heterodimers with leucine-rich repeat kinase 1 (LRRK1) and death-associated protein kinase 1 (Klein et al. 2009; Dachsel et al. 2010) . This suggests that LRRK2 enzymatic regulation could similarly occur in trans, between neighboring LRRK2 subunits or between LRRK2 and its neighboring binding partners, and hence dimerization may be crucial for governing GTPase activity (Guaitoli et al. 2016) . However, further exploration of this possibility has been hampered by low expression levels of recombinant human LRRK2.
Study of human LRRK2 has been benefited by comparison with prokaryotic homologues. A crystal structure of the nucleotide-free state of Roc and COR domains of a prokaryotic Roco family member expressed in the bacterium Chlorobium tepidum showed that the COR domain comprises two globular subdomains (Gotthardt et al. 2008) . Deyaert, et al . demonstrated that C. tepidum Roc-COR protein forms dimers when it is in the nucleotide-free state or complexed with Mg 2+ -GDP but forms monomers when complexed with Mg 2+ -GTP. Furthermore, its transition between the dimeric and monomeric states is a dynamic process governed by GTP turnover (Deyaert et al. 2017) .
The molecular basis of enzymatic regulation in LRRK2 and its prokaryotic homologs has yet to be comprehensively defined. However, previous findings have supported a possible functional similarity with the family of G-proteins activated by dimerization (GADs) [reviewed in (Gasper et al. 2009; Nixon-Abell et al. 2016) ]. In order to efficiently catalyze GTP hydrolysis, GADs require intermolecular interactions between dimeric units to assemble the active site appropriately for efficient catalysis. GADs are also distinguished from other GTPases by their much lower affinities for guanine nucleotides (with K D in the lM range) [refer to (Wittinghofer and Vetter 2011) for review]. Results of biochemical and structural analyses of the Roc-COR domains of Roco proteins from prokaryotes C. tepidum and Methanosarcina barkeri confirm that they possess properties of GADs (Gotthardt et al. 2008; Terheyden et al. 2015) . A role for dimerization in catalytic regulation, as observed for GADs, is supported by the ability of full-length human LRRK2 and LRRK2 Roc domain to form dimers in solution (Sen et al. 2009; Ito and Iwatsubo 2012; Liao et al. 2014; Guaitoli et al. 2016; Sejwal et al. 2017) and the low affinities exhibited by LRRK2 Roc domain for GDP and a GTP analog (K D3 -7 lM) (Liao et al. 2014) . Because of the technical challenges posed by expressing sufficient quantities of high-quality recombinant human LRRK2 Roc-COR tandem domain, one of our objectives is to overcome these challenges to express a recombinant protein consisting of this LRRK2 tandem domain for detailed biochemical analyses and future structural studies. Specifically, we have addressed three key questions: (i) What is the appropriate LRRK2 construct suitable for high-level expression and purification of active recombinant LRRK2 Roc-COR tandem domain? (ii) Does the recombinant protein consisting of just the LRRK2 Roc-COR tandem domain functions as a GAD or as a conventional Ras-like GTPase? (iii) How does the PD-causative Y1699C mutation impact the structure and catalytic activity of recombinant LRRK2 Roc-COR domain? This manuscript describes the design and expression of a catalytically active recombinant LRRK2 fragment consisting of the Roc-COR tandem domain. Results of our analysis suggest that the Roc-COR tandem domain exhibits both GAD-like and conventional Ras-like GTPase properties -it forms homodimers like GADs and yet functions like the conventional Ras-like GTPases in binding guanine nucleotides and hydrolyzing GTP. Our analysis of the Y1699C mutant of the LRRK2 Roc-COR tandem domain revealed that the mutation has no significant impact on its stability and catalytic activity.
Materials and methods
This study was not pre-registered and that pre-registration was not required.
Materials
The pcDNA3-LRRK2 plasmid for generating LRRK2 Roc-COR was a kind gift of Dr. M. J. Farrer of the University of British Columbia. The gene encoding the LRRK2 (1324-1858) segment was synthesized by Genscript (RRID:SCR_002891). The gene encoding mouse Rac1 (Uniprot ID P63001) with an N-terminal HA tag was synthesized by Bioneer Pacific (Melbourne, Vic., Australia). The pGEX6P3 vector and the pBacPAK9 vector were from GE Bioscience (RRID:SCR_000004) (Silverwater, N.S.W., Australia) and Clontech (RRID:SCR_004423) (Takara Bio USA, Mountain View, CA., U.S.A), respectively. The Quick-Change II site directed mutagenesis kit was from Agilent Technologies (Santa Clara, CA., U.S.A.). Grace's medium supplemented with 10% (v/v) fetal bovine serum and Sf-900 TM II serum-free medium (Cat #: 10902104) for insect cell culture were purchased from Thermo-Fisher (Waltham, MA., U.S.A.) . The Spodoptera frugiperda clone 9 and clone 21 cell lines (Sf9 and Sf21 cell lines; RRID: CVCL_0549 and CVCL_0518, respectively) were from Thermo-Fisher (RRID:SCR_008817); they are not listed as commonly misidentified cell lines by the International Cell Line Authentication Committee. The glutathione-agarose for purification of GST (glutathione-S transferase)-LRRK2 Roc-COR was from GE Healthcare (RRID:SCR_000004) (Siverwater, N.S.W., Australia). Carrier-free [ 32 P] inorganic phosphate was from Perkin-Elmer (Waltham, MA., U.S.A.). GDP, GTP, and the sequencing grade trypsin were from Sigma-Aldrich (RRID: SCR_008988) (St. Louis, MO., U.S.A.). The HPLC instrument (Agilent HPLC-Chip Cube MS Interface from G4240A) was from Agilent Technologies (Santa Clara, CA, USA). The mass spectrometer relied on LTQ Orbitrap XL Hybrid Ion Trap-Orbitrap was from Thermo-Fisher. All other chemicals used in our study were of analytical grade. No experimental models were used in this study. Thus, institutional approval for the use of animals was not required.
Plasmids for expression of LRRK2 Roc-COR and short LRRK2 Roc-COR in E. coli and baculovirus-infected insect cells To generate the plasmids for expression of LRRK2 Roc-COR proteins with different affinity tags, we cloned the cDNA encoding the human LRRK2 (1314-1878) segment from the pcDNA3-LRRK2 plasmid by PCR (Data S1). For expression of LRRK2 (1314-1878) with different affinity tags in insect cells and/or E. coli, the PCR product was subcloned to the pBacPAK9 vector and the pGEX6P3 vector, respectively (Data S1).
For expression of the short LRRK2 Roc-COR, the gene encoding the LRRK2 (1324-1858) segment with a poly-His and a Flag tag at the Nterminus and an HA tag at the C-terminus was synthesized by Genscript prior to subcloning into the pBacPAK9 vector. The resultant pBacPAK9-LRRK2 (1324-1858) plasmid was used to generate the baculovirus to direct expression of the short LRRK2 Roc-COR protein.
The truncated LRRK2 Roc-CORDC mutant lacks the C-terminal portion of the COR domain and the linker connecting the COR and kinase domains. For its expression, the gene encoding the LRRK2 (1314-1673) segment with a poly histidine tag (His 6 ) at the Cterminus and a Flag tag at the N-terminus was amplified by PCR. The reaction product was subcloned into the pBacPAK9 vector. The resultant LRRK2 Roc-CORDC-pBacPAK9 plasmid was used to generate the recombinant baculovirus to direct expression of the LRRK2 Roc-CORDC mutant.
Purification of GST-LRRK2 Roc-COR expressed in E. coli and Sf9 cells Transformed E. coli or baculovirus-infected Sf9 cells were lysed by homogenization in lysis buffer (25 mM HEPES, 1 mM EDTA, 0.2 mg/mL benzamidine, 0.1 mg/mL phenylmethylsulfonylfluoride (PMSF), 1 mM b-mercaptoethanol, 0.1 mg/mL soybean trypsin inhibitor, pH 7). For purification from E. coli, lysozyme was added to the lysis buffer to a final concentration of 0.1 mg/mL to facilitate lysis of the bacterial cell wall. Where Sf9 cells were used, lysis buffer was supplemented with 1 % (v/v) NP-40 to disrupt the cell membrane. Insoluble material was pelleted by centrifugation at 34 540 g for 20 min at 4°C and the supernatant was incubated with glutathione-agarose with rocking at 4°C for 20 min. The agarose was rinsed with 25 mM HEPES, 1 mM EDTA, 0.2 mg/mL benzamidine, 0.1 mg/mL PMSF, 1 mM b-mercaptoethanol, pH 7, and washed with the same buffer plus 0.5 M NaCl in order to remove non-specifically bound proteins. Proteins bound to the glutathione-agarose were eluted with 25 mM HEPES, 0.2 mg/mL benzamidine, 0.1 mg/mL PMSF, 2 mM b-mercaptoethanol, 20 mM glutathione, pH 7 and dialyzed to 25 mM HEPES, 0.1 mg/mL PMSF, 1 mM b-mercaptoethanol, pH 7.
Generation of recombinant [T1348N]LRRK2 Roc-COR and [Y1699C]LRRK2 Roc-COR
We used the Quick-Change II site-directed mutagenesis kit to generate two mutants of LRRK2 Roc-COR by introducing the T1348N or Y1699C mutations to the pBacPAK9-LRRK2 (1314-1878) plasmid. The resultant plasmids were used to generate the recombinant baculovirus that direct expression of the LRRK2 Roc-COR mutants.
Purification of recombinant LRRK2 Roc-COR and its mutants, and short LRRK2 Roc-COR For large-scale production (up to 10 mg) of purified recombinant LRRK2 Roc-COR, [Y1699C]LRRK2 Roc-COR, [T1348N]LRRK2 Roc-COR, LRRK2 Roc-CORDC, and short LRRK2 Roc-COR, Sf9 cells (1 L at a cell density of 0.8-1 9 10 6 cells per mL) or Sf21 (1 L at a cell density of 2-2.5 9 10 6 cells per mL) were infected with the recombinant baculovirus at an multiplicity of infection (MOI) ≥ 1. At 48 h after infection, the infected insect cells were pelleted by centrifugation at 1580 g at 4°C. Cell pellets were first re-suspended in 3 mL lysis buffer (30 mM Tris, pH 8.0, 150 mM NaCl, 0.1 mg/ mL PMSF and 1 % NP-40) prior to homogenization with a Dounce homogenizer. The homogenate was centrifuged at~35 000 g for 20 min at 4°C. The supernatant containing the recombinant LRRK2 Roc-COR protein or its mutants was loaded onto a Ni 2+ -NTA agarose column (10 mL of packed volume). The agarose beads were rinsed with Column Buffer (30 mM Tris, 150 mM NaCl, 0.1 mg/ mL PMSF, pH 8) to remove the unbound proteins. They were subsequently washed with the same buffer supplemented with 30 mM imidazole. Proteins bound to the agarose were eluted in Column Buffer with 300 mM imidazole. The peak protein-containing fractions were pooled and dialyzed in Column Buffer prior to biochemical analysis.
Expression and purification of mouse Rac1
The synthetic gene encoding mouse Rac1 (Uniprot ID P63001) with an N-terminal HA tag was subcloned via the BamH1 and EcoR1 sites to the pGEX6P3 vector directing expression of an N-terminal glutathione S-transferase (GST)-tagged recombinant protein. The resultant pGEX6P3 plasmid was used to transform BL21 (DH3) cells. The transformed BL21 (DH3) cells were grown at 37°C to a cell density that gave an OD 600 = 0.5 prior to induction with 0.1 mM isopropyl b-D-1-thiogalactopyranoside. The induced cells were cultured further at 16°C for 16-18 h before they were harvested by centrifugation at 3000 g for 15 min. The cell pellets were lysed by sonication in Buffer A (10 mM HEPES, 250 mM NaCl, 10 mM MgCl 2 , 10 mM glycine, 5% glycerol, 2 mM benzamidine, 0.1 mg/mL PMSF, 1 mM bmercaptoethanol, pH 8.0) supplemented with 10 lM GTP and 1 mg/ mL lysozyme to facilitate lysis of the bacterial cell wall. After centrifugation of the homogenate at 35 000 g for 20 min at 4°C, the supernatant containing the recombinant GST-HA-Rac1 was incubated for 90 min with glutathione-agarose pre-equilibrated with Buffer A. The GST-HA-Rac1 bound glutathione-agarose was washed with 20 mL Buffer A to remove the non-specifically bound proteins. Buffer A with 20 mM reduced glutathione was used to elute the bound GST-HA-Rac1. The purified proteins were aliquoted and stored at À80°C prior to biochemical analyses.
Determination of the secondary structure contents of recombinant LRRK2 Roc-COR and [Y1699C]LRRK2 Roc-COR by circular dichroism spectroscopy Circular dichroism (CD) spectra were recorded from 5 lM and 300 lL purified LRRK2 Roc-COR and [Y1699C]LRRK2 Roc-COR in a quartz cuvette (1 mm path length) in a temperature-controlled sample chamber attached to a Jasco circular dichroism spectropolarimeter. Spectra were collected from 190 to 260 nm, recording one data point per nm, with a bandwidth of 1 nm and a scanning speed of 20 nm/min. CD spectra were obtained from three independent scans. A representative spectrum was used to estimate secondary structure contents. For secondary structure estimation, data for the range 200 to 250 nm were fitted to the Bestsel prediction program (Micsonai et al. 2015) containing reference proteins with varying secondary structures.
Determination of the protein concentrations of the purified recombinant enzymes Concentrations of the purified proteins we generated were quantified by measurement of the absorbance of the protein preparations at 280 nm and calculation using the molar extinction coefficient of 76 320, 74 830, and 75 033 M À1 cm À1 for LRRK2 Roc-COR,
[Y1699C]LRRK2 Roc-COR, and Rac1, respectively.
GTPase activity assays GTP hydrolysis catalyzed by purified LRRK2 Roc-COR and its mutants was measured by the release of radio-labeled inorganic phosphate from [c-32 P]GTP as described previously by us and Foulkes, et al. to monitor tyrosine phosphatase activity (Foulkes et al. 1981; Chia et al. 2010) . In brief, the purified enzymes diluted to the designated concentrations were incubated at 30°C with 30 mM Tris, pH 8.0, 1 mM MgCl 2 , and 100 nM [c-32 P]-GTP (specific radioactivity:~5000 cpm/pmol) in a final volume of 25 lL for the indicated time periods. The GTP hydrolysis reaction was stopped by addition of 50 lL of a mixture consisting of 1.25 mM KH 2 PO 4 and 0.5 M H 2 SO 4 . Released [ 32 P]inorganic phosphate was complexed with 100 lL of 5 % (w/v) ammonium molybdate. The phosphate-molybdate complex was extracted by the addition of 200 lL mixture of isobutanol and toluene mixed at a ratio of 1 : 1 (v/v). The mixtures were centrifuged at 9450 g for 1 min to separate the aqueous and organic phase; 150 lL of the upper organic phase containing the molybdate-bound phosphate was taken out and mixed with scintillant (Ultima Gold XR; Perkin Elmer Parkard Bioscience (Waltham, MA., U.S.A.)) prior to scintillation counting. The specific enzymatic activities of LRRK2 Roc-COR, [Y1699C]LRRK2 Roc-COR, and Rac1 were determined from the radioactivity associated with the organic phase. For the 'blank' reaction of the assay, the aliquot of the diluted enzyme was replaced by an aliquot of the elution buffer of a similar volume. -NTA agarose was divided into two portions. For the first portion, the bound protein was eluted by incubation with 250 mM imidazole in column buffer. The eluted proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. An aliquot from each column fraction (5 lL out of a final volume of 100 lL) was spotted onto a Whatman 3MM filter paper. The radioactivity associated with each fraction was recorded by autoradiography. For the second portion, the suspension of LRRK2 Roc-COR-bound Ni 2+ -NTA agarose was heat-treated at 95°C for 5 min. After centrifugation, the supernatant contained the radioactively labeled compound(s) released from LRRK2 Roc-COR immobilized to Ni 2+ -NTA agarose. For thin layer chromatography (TLC) analysis, an aliquot of the supernatant was spotted onto a PEI Cellulose F TLC plate, and chromatographed for 1.5 h in 1 M KH 2 PO 4 , pH 3.4. Unlabeled GDP and GTP standards (30 nmol each) were included as controls. After chromatography, migration of the GTP and GDP standards was visualized by illumination with UV light. The [ 32 P] inorganic phosphate was detected by exposure to a phosphor-screen and imaged on a Typhoon phosphoimager at 200 nm per pixel. Identities of the radioactively labeled compounds co-purified with LRRK2 Roc-COR were determined by their co-migration with the standards.
Determination of metal ions in the purified LRRK2 Roc-COR preparations by ICP-MS and ICP-AES
To prepare the samples for inductively coupled plasma mass spectrometry (ICP-MS) analysis, LRRK2 Roc-COR and [Y1699C] LRRK2 Roc-COR preparations expressed in Sf21 cells cultured in the serum-free medium were purified by Ni 2+ -NTA agarose. The purified samples were dialyzed against the 4 9 1 L of dialysis buffer (20 mM Tris, 150 mM NaCl, 10 % (v/v) glycerol, pH 8.0). The dialyzed protein samples (at concentrations ranging from 6.6 to 12.5 lM) were used for analysis by ICP-MS. To prepare for ICP-MS, the diluted samples were further diluted 1/5 with 1 % (v/v) nitric acid in triplicate. Measurements were made using an Agilent 7700 series ICP-MS instrument under routine multi-element operating conditions using a Helium Reaction Gas Cell. The instrument was calibrated using 0, 5, 10, 50, 100, and 500 parts per billion ( Table S1 .
To prepare the protein sample for ICP atomic emission spectroscopy (ICP-AES) analysis, LRRK2 Roc-COR expressed in Sf9 cells cultured in Grace's complete media was purified by Ni 2+ -NTA column chromatography. After dialysis against 30 mM Tris, 150 mM NaCl, 0.1 mg/mL PMSF, pH 8.0, the purified protein sample (30 lg) was diluted to a final concentration of 0.01 mg/mL in 0.25 % (v/v) HNO 3 and 8 g/L CsCl (to suppress ionization of Na, K, Ca and Mg), and with 1 mg/L Rh and 1 mg/L Rb as internal standards to monitor ionization. The diluted LRRK2 Roc-COR protein samples were analyzed alone, and with addition of standards containing the indicated elements at 1, 0.1, and 0.01 mg/L, using a Vista AX charged-couple device simultaneous ICP atomic emission spectrometer (Agilent-Varian Santa Clara, CA., U.S.A.). Briefly, the sample was atomized in a nebulizer and injected directly into inductively coupled plasma (Argon gas, 6000-8000 K). Light resulting from atomic emission was diffracted by an echelle grating and detected by a charged-couple device camera. Atomic emission spectra were recorded, and intensities at the indicated wavelengths for each element were analyzed by comparing the LRRK2 Roc-COR samples alone with separate samples to which standards of known concentrations had been added. Sample intensity was subtracted from intensities of the standards, and a linear regression was performed. This allows the conversion of the measured intensity to the concentration of each element. Measured intensities for each element in the LRRK2 Roc-COR sample and in the buffer only sample were converted to concentration in mg/L. The concentration of Mg 2+ co-purified with LRRK2 Roc-COR was determined by subtracting the concentration of Mg 2+ in the buffer only sample from that in the LRRK2 Roc-COR sample.
Statistical analyses
No randomization or blinding was performed in this study. Assays of the GTPase activities of all recombinant proteins were conducted by more than one of the authors. All GTPase assays and the ICP-MS experiments were performed at least twice and with triplicate samples. More than five enzyme preparations of LRRK2 Roc-COR and [Y1699C]LRRK2 Roc-COR were used to perform the assay. The enzymatic activities of LRRK2 Roc-COR and its mutants were presented as the mean AE SD. All statistical analyses of GTPase activity assay data were performed with student t-test and the Graphpad Prism software Version 7 (La Jolla, CA., U.S.A.). All data points were included in the results presented. Thus, we did not conduct a test for outliers on the data.
Results
Design of LRRK2 constructs to optimize expression of recombinant LRRK2 Roc-COR tandem domain The functions of the two catalytic domains of LRRK2 have so far been explored using full-length LRRK2 immunoprecipitated from mammalian cells, two recombinant proteins containing the isolated LRRK2 Roc domain produced in E. coli (Deng et al. 2008; Liao et al. 2014) , a fragment containing the Roc, COR, and kinase domains (Rudi et al. 2015) and a fragment comprising the LRR, Roc, COR, kinase, and WD40 domains (Anand et al. 2009 ). In order to further elucidate the function of the COR domain and assess the effects of the PD-causative Y1699C mutation mapped to the COR domain, a LRRK2 construct and its mutants consisting of the Roc and COR domains were produced for biochemical characterizations We defined the LRRK2 Roc and COR domains to reside in the segment containing residues 1331-1840 of the human LRRK2 sequence with the aid of (i) alignment of Roco family members from diverse species (Bosgraaf and Van Haastert 2003; Civiero et al. 2012; Sejwal et al. 2017 ) and (ii) alignment of the LRRK2 sequence with sequences of Ras and the Roc-COR tandem domain of two prokaryotic Roco proteins with known three-dimensional structures (Gotthardt et al. 2008; Mills et al. 2012 Mills et al. , 2014 Terheyden et al. 2015) ( Figure S1 ). The N-terminal truncation site (residue 1314) was chosen to include a loosely conserved region of 27 residues N-terminal of the Roc domain P-loop; this region was predicted to be a linker between the LRR and Roc domains ( Figure S1 ). Truncation at this distance from the Ploop matches many structurally stable truncations of Ras-like GTPases, and therefore was expected to minimize the impact of the truncation on the structure of the Roc domain. Determination of the truncation site at the C-terminus, on the other hand, presented a more difficult undertaking, as this region exhibits low sequence similarity to the successfully expressed and folded recombinant C. tepidum and M. barkeri Roco proteins, with potentially unpredictable effects on structure. Thus, we decided to include most of the putative linker connecting the COR domain to the kinase domain, in order to minimize the impact of truncation on the structural integrity of the COR domain. The chosen C-terminal truncation site (residue 1878) is seven residues N-terminal to the glycine-rich loop of the kinase domain. The resultant construct consisting of residues 1314-1878 of the LRRK2 sequence was used to generate three recombinant LRRK2 GTPase proteins expressed in E. coli and in baculovirusinfected insect cells (Fig. 1) . To facilitate their purification and detection, a poly-histidine (His 6 ) tag was added at the C-terminal end and a Flag or a GST-tag at the N-terminus of the recombinant proteins. Their expression levels and purities after affinity column chromatography were assessed. As listed in Fig. 1 , expression levels of GST-LRRK2 (1314-1878) in E. coli and baculovirus-infected Sf9 cells were low and the protein preparations after glutathione (GSH)-affinity column chromatography still contained several major protein contaminants (data not shown). In contrast, the Flag-LRRK2 (1314-1878) was expressed at a much higher level in baculovirus-infected insect cells. Furthermore, it could readily be purified by Ni 2+ -NTA affinity column chromatography (Fig. 2a) . This recombinant LRRK2 fragment, which was used in biochemical analyses described in this manuscript, is referred to as LRRK2 Roc-COR.
To ascertain the impact of deletion of part of the linker connecting the LRR and Roc domains and that connecting the COR and kinase domains on the expression of LRRK2 GTPase, we generated the baculovirus directing expression of a shorter fragment (residues #1324-1858) of LRRK2. This shorter version of LRRK2 Roc-COR, referred to as short LRRK2 Roc-COR, consists of the intact Roc and COR domains as well as the truncated linkers at both the Nterminal and C-terminal ends (Fig. 1) . We found that short LRRK2 Roc-COR was expressed in insect cells at a level much lower than that of LRRK2 Roc-COR. Furthermore, a number of major protein contaminants were co-purified with short LRRK2 Roc-COR ( Figure S2 ). Taken together, our results suggest that the linker of LRR and Roc domains and/ or that of the COR and Kinase domains stabilize LRRK2 GTPase and enhance its expression in insect cells. Of relevance, MASL1, the smallest human Roco protein, contains just the Roc-COR domain flanked by a long Nterminal segment (residues 1-406) and a short C-terminal segment (residues 1029-1052 ( Figure S3 ). Similar to the role of the linker of the LRR and Roc domains and that of the COR and kinase domains of LRRK2, the N-and C-terminal segments may stabilize the structure of the MASL1 Roc-COR domain.
LRRK2 Roc-COR is folded, and migrates as a dimer in solution LRRK2 Roc-COR was expressed at relatively high level [~10 mg/L of Sf21 cell culture (cell density: 2.0-2.5 9 10 6 cells per mL)] and purified to over 90% purity by Ni 2+ -NTA affinity column chromatography (Fig. 2) . Its authenticity was confirmed by LC-MS/MS analysis of its tryptic fragments ( Figure S4 ). Circular dichroism analysis of its secondary structure contents revealed that it is folded (Fig. 2b) . The theoretical molecular mass of monomeric LRRK2 Roc-COR is 67 kDa. From the mobility of LRRK2 Roc-COR relative to those of the molecular size standards in the size exclusion column chromatography ( Fig. 2c and d) , we determined the molecular mass of LRRK2 Roc-COR to be 111 kDa. The deviation of this value from that of the theoretical molecular mass (134 kDa) LRRK2 Roc-COR dimer suggests two possibilities. First, LRRK2 Roc-COR exists as a dimer in solution, and the deviation is a result of the low resolution of size exclusion column chromatography method. Second, LRRK2 Roc-COR exits a monomer with unique molecular shape such that it eluted from the size exclusion column with a molecular mass (111 kDa) significantly higher than the theoretical molecular mass (67 kDa) of the LRRK2 Roc-COR monomer.
The crystal structures of the two prokaryotic Roc-COR domains reveal that determinants governing their dimerization mainly reside in the C-terminal portion of the COR domain (Gotthardt et al. 2008; Terheyden et al. 2015) . A truncation mutant of M. barkeri Roc-COR (Roc-CORDC) lacking this portion of the COR domain existed as a monomer in solution, and exhibited much lower GTPase activity than that of wild type Roc-COR (Terheyden et al. 2015) . We therefore attempted the same approach to explore whether the C-terminal portion of the COR domain mediates dimerization of LRRK2 Roc-COR, and whether dimerization enhances its GTPase activity. The C-terminal portion of LRRK2 COR domain was predicted to encompass residues 1674-1840 by alignment of the sequences of LRRK2, C. tepidum Roco and M barkeri Roco ( Figure S1 ) and by inspecting the structure of C. tepidum Roco in Fig. 3a) . Based upon this prediction, we designed and generated the recombinant LRRK2 Roc-CORDC encompassing residues 1314 to 1673 of human LRRK2, flanked by an N-terminal Flag tag and a C-terminal poly-His tag (Fig. 1b and b) . We were able to purify the recombinant LRRK2 Roc-CORDC from the lysate of the infected Sf21 cells using Ni 2+ -NTA affinity column chromatography ( Figure S5 ). However, the purified LRRK2 Roc-CORDC readily aggregated to form precipitates in solution. In spite of this property, we managed to use the soluble recombinant LRRK2 Roc-CORDC to determine its molecular mass by size exclusion chromatography. Figure 3d shows that it migrated as a protein of 43 kDa (theoretical monomeric molecular mass: 43.7 kDa) in the chromatographic run ( Fig. 3c and d) , suggesting that it exists as a monomer in solution.
Taken together, our data suggest that LRRK2 Roc-COR forms homodimers in solution, and the C-terminal portion of the COR domain governs its dimerization.
Mg
2+ and guanine nucleotides co-purified with LRRK2 Roc-COR Whether the enzymatic properties of LRRK2 Roc-COR domains match more closely with those of the conventional Ras-like GTPases or with those of the numerous emerging examples of GADs, is an outstanding question in the field of LRRK2 research. To address this question, we attempted to measure the affinity of the LRRK2 Roc-COR for two fluorescent GTP analogs: 2 0 -(or-3 0 )-O-(N-methylanthraniloyl)-GTP (mant-GTP) and its non-hydrolyzable analog mant-GMPPNP. However, we failed to detect significant binding of mant-GTP or mant-GMPPNP to LRRK2 Roc-COR (data not shown). One potential explanation for this observation is that unlike the LRRK2 Roc domain, which binds guanine nucleotides with relatively low affinity (Liao et al. 2014) , LRRK2 Roc-COR binds guanine nucleotides tightly. As such, most of the recombinant LRRK2 Roc-COR molecules used in our analysis may have already had a co-purified Mg 2+ -GTP or Mg 2+ -GDP tightly bound to their active site. Consequently, they were unable to exchange the bound Mg 2+ -GTP and Mg 2+ -GDP for the exogenous mant-GTP and mant-GMPPNP under the conditions we conducted the analysis. In agreement with this explanation, the UV absorption spectrum of the purified LRRK2 Roc-COR preparation revealed significant absorption at 260 nm, suggesting the presence of UV-absorbing materials copurified with LRRK2 Roc-COR (Fig. 4a) . The likely candidates of the UV-absorbing material at 260 nm are guanine nucleotides. Relevant to this, Poe et al. (1985) reported that recombinant viral K-Ras with GDP bound to its active site at 1 : 1 stoichiometry also gave a UV-visible absorption spectrum with significant UV absorption at 260 nm. Thus, these findings suggest that significant UV absorption at 260 nm found in the UV-visible absorption spectra of LRRK2 Roc-COR (Fig. 4a) is caused by the guanine nucleotides tightly bound to their active sites.
To confirm that LRRK2 Roc-COR is capable of tight binding to guanine nucleotides in cells, and to determine whether the Fig. 1 The seven recombinant LRRK2 protein constructs generated. (a) Functional domains of LRRK2. (b) A summary of expression systems, purities, yields, and stabilities of the six recombinant protein constructs containing the LRRK2 Roc-COR domains and the linkers connecting the tandem domain to the LRR and kinase domains. The numbers in the second column indicate residue numbers of the human LRRK2 sequence. COR, C-terminal of Roc; Roc, Ras of complex; LRRK2, leucine-rich repeat kinase 2.
GTP-or GDP-bound form predominates, bound nucleotides were examined in LRRK2 Roc-COR purified from infected Sf9 and Sf21 cells metabolically labeled with 32 P-inorganic phosphate. As shown in Fig. 4(c) and Figure S6 , LRRK2 Roc-COR was co-purified with a radioactive compound. This tightly bound radioactive compound dissociated from LRRK2 Roc-COR upon heat treatment of the purified protein preparations. TLC of the released radioactive compound with GTP and GDP standards shows that GTP was the guanine nucleotide copurified with LRRK2 Roc-COR expressed in Sf21 cells cultured in serum-free media (Fig. 4c) . Interestingly, GDP was the radioactive compound co-purified with LRRK2 Roc-COR expressed in Sf9 cells cultured in Graces' media supplemented with 10% fetal bovine serum ( Figure S6c ). The predominance of GTP bound to LRRK2 Roc-COR expressed in Sf21 cells cultured in serum-free media (Fig. 4) suggests that the GTPase activity of recombinant LRRK2 Roc-COR was suppressed in these cells. In contrast, LRRK2 Roc-COR expressed in Sf9 cells cultured in Graces' medium with fetal bovine serum was more catalytically active and capable of hydrolyzing all the bound GTP to GDP ( Figure S6 ). Why LRRK2 Roc-COR proteins expressed in different types of insect cells and/or cultured in different media exhibit different catalytic activity in cells remains unclear. Nevertheless, our data suggest that similar to the conventional Ras-like GTPases, LRRK2 Roc-COR binds both GTP and GDP with very high affinities.
GTPases bind guanine nucleotides complexed with a Mg detected in the purified preparations of LRRK2 Roc-COR were determined from the raw ppb values (Table S1) . From these concentrations, the stoichiometry of Mg 2+ co-purified with LRRK2 Roc-COR determined in the three replicates ranges from 0.8 to 1.0 mol/mol of protein (Fig. 5a ). In addition to ICP-MS, inductively coupled plasma atomic emission spectroscopy (ICP-AES) was also used to measure the magnesium ions co-purified with LRRK2 Roc-COR expressed in Sf9 cells (Fig. 5b) . Our measurement also reveals a stoichiometry of~1.0 mol. of Mg 2+ per mol of LRRK2 Roc-COR.
Thr-1348 of LRRK2 corresponds to the conserved active site threonine residue critical to binding of guanine nucleotides in GTPases ( Figure S1 ). Its mutation is predicted to abolish the GTP-binding ability and GTPase activity of LRRK2-Roc-COR. We therefore generated the [T1348N] LRRK2 Roc-COR mutant to investigate if Mg 2+ and GTP (Figs 3c and 4) co-purified with LRRK2 Roc-COR were stoichiometrically bound to its active site. Similar to the effect of the T1348N mutation on the GTPase activity of fulllength recombinant LRRK2 (Ito et al. 2007; Biosa et al. 2013) , this mutation completely abolished the GTPase activity LRRK2 Roc-COR ( Figure S7 ). Additionally, this mutation significantly reduced the expression level of the LRRK2 Roc-COR mutant (data not shown). The low yield of this mutant recombinant protein preparation prevented us from carrying out the ICP-MS or ICP-AES experiments to ascertain if this mutation abolishes the ability of LRRK2 Roc-COR to bind Mg 2+ and guanine nucleotides. In summary, the consistent presence of Mg 2+ at close to 1 : 1 stoichiometry in the LRRK2 Roc-COR preparations determined by both ICP-MS and ICP-AES (Fig. 5 ) and the demonstration of tight binding of guanine nucleotides to LRRK2 Roc-COR (Fig. 3 and Figure S6 ), suggest that LRRK2 Roc-COR contains Mg 2+ -GTP or Mg 2+ -GDP bound to its active site at close to 1 : 1 stoichiometry.
It took us~6 h to purify the recombinant LRRK2 Roc-COR from the Sf21 cells metabolically labeled with [ 32 P]-inorganic phosphate. In spite of such a long period of purification, we did not detect a significant amount of radioactive GDP in the guanine nucleotide co-purified with LRRK2 Roc-COR. Instead, GTP was the only detectable guanine nucleotide co-purified with LRRK2 Roc-COR (Fig. 4c) . These results suggest that the intrinsic GTPase activity of LRRK2 Roc-COR is so low that we were unable to detect the GDP generated as a result of hydrolysis of the tightly bound GTP.
LRRK2 Roc-COR exhibits weak GTPase activity with a nanomolar K m value Although our data shown in Figs 4 and 5 indicate that the majority of the purified LRRK2 Roc-COR protein molecules were tightly bound to Mg 2+ -GTP, the purified LRRK2 Roc-COR preparation still exhibited weak GTPase activity (Fig. 6a) . Furthermore, this weak activity is abolished when Thr-1348 critical to binding of guanine nucleotides is mutated to Asn ( Figure S7 ). We first compared the specific enzymatic activity of LRRK2 Roc-COR with that of a conventional Ras-like GTPase Rac1. Our analysis revealed that the specific enzymatic activity of LRRK2 Roc-COR is almost as low as that of Rac1 under the conditions we performed the assay (Fig. 6b) . Thus, similar to Rac1, the weak GTPase activity of LRRK2 Roc-COR is likely caused by the slow exchange of the bound guanine nucleotide with exogenous [c-32 P]GTP as well as the low intrinsic efficiencies of its active site in catalyzing hydrolysis of the bound GTP.
To define the enzymatic properties of LRRK2 Roc-COR, we performed kinetic analysis of its GTPase activity. Figure 6 (c) shows that LRRK2 Roc-COR catalyzed GTP hydrolysis with K m of 22 nM. The nanomolar K m value is in agreement with our findings presented in Figs 3 and 4 , which suggest that LRRK2 Roc-COR binds Mg 2+ -GDP/GTP tightly. The tight binding limits turnover of guanine nucleotides in the catalytic cycle of GTP hydrolysis catalyzed by LRRK2 Roc-COR, accounting for the very low k cat value (0.47 9 10 À3 min À1 ) of its GTPase activity.
From this k cat value, we calculated the turnover time for the hydrolysis of one molecule of GTP by each molecule of LRRK2 Roc-COR to be 2127.65 min (~35.5 h). Such a long turnover time explains why we failed to detect GDP as a guanine nucleotide co-purified with LRRK2 Roc-COR from the infected Sf21 cells metabolically labeled with [ 32 P]-inorganic phosphate (Fig. 4c) -the turnover time is significantly longer than the duration (6 h) we took to isolate LRRK2 Roc-COR prior to releasing the bound guanine nucleotide for TLC analysis.
Several groups of researchers have performed kinetic analysis of the GTPase activity of full-length LRRK2 and two truncated LRRK2 fragments (i) LRRK2(Roc-COR/ kinase) consisting of the Roc-COR and kinase domains and (ii) LRRK2(LRR-WD) containing LRR, Roc-COR, kinase, and WD40 domains (Table 1) (Liu et al. 2010 (Liu et al. , 2012 Rudi et al. 2015) . These researchers separately revealed that fulllength LRRK2 and truncated LRRK2 mutants with both intact Roc-COR and kinase domains catalyzed GTP hydrolysis with K m values (210-700 lM) much higher than that of LRRK2 Roc-COR, and with k cat values much higher than that of LRRK2 Roc-COR (Table 1) . These results suggest that the presence of kinase domain and other functional domains somehow reduces the affinity of the Roc-COR domain for guanine nucleotides; the lower affinity likely allows a higher turnover rate of guanine nucleotides in catalysis. Hence, full-length LRRK2 and LRRK2 fragments consisting of intact Roc-COR, kinase domains and other functional domains are predicted to hydrolyze GTP with catalytic efficiencies higher than that of LRRK2 Roc-COR. In agreement with this prediction, we found that the specific enzymatic activities of LRRK2(LRR-WD) and its G2019S mutant are~8-to 10-fold higher than that of LRRK2 Roc-COR (Table 1, Figure S8 ).
Taken together, our data shown in Figs 4, 5, and 6(c) indicate that similar to the conventional Ras-like GTPases, LRRK2 Roc-COR in isolation binds guanine nucleotides with high affinities and catalyzes GTP hydrolysis with a very low efficiency. Results shown in Table 1 and Figure S8 suggest that in the presence of other functional domains, LRRK2 GTPase domain catalyzes GTP hydrolysis with a higher K m and a higher k cat. -NTA agarose chromatography, dialyzed and subjected to ICP-AES, either alone or with addition of standards at 1, 0.1, and 0.01 mg/L. Measured intensity at the specified wavelength for magnesium ions were buffer-subtracted and converted to concentrations. The concentration of LRRK2 Roc-COR used was 1.93 AE 0.11 lM. From the intensity of signal at the wavelength of 279.553 nm, the concentration of Mg 2+ was calculated to be 2.05 AE 0.14 lM. Stoichiometry of Mg 2+ bound to LRRK2 Roc-COR was determined from these concentrations. The error bar indicates SEM of three replicate measurements. COR, C-terminal of Roc; Roc, Ras of complex; LRRK2, leucine-rich repeat kinase 2.
The PD-causative Y1699C mutation does not perturb the secondary structural contents, guanine nucleotide-binding capacity and catalytic activity of LRRK2 Roc-COR We generated the [Y1699C]LRRK2 Roc-COR to examine how the PD-causative Y1699C mutation impacts on the secondary structure contents, guanine nucleotide-binding capacity and GTPase activity of LRRK2 Roc-COR. Figure S9 shows that [Y1699C]LRRK2 Roc-COR was expressed at a relatively high level and purified to a similar purity as the wild-type LRRK2 Roc-COR protein. Tyr-1699 was predicted to reside at the interface between the Roc and COR domains. Thus, Y1699C mutation can potentially perturb the interactions between the two domains, and this in turn can potentially impact the GTPase activity and stability of LRRK2 Roc-COR domain (Mills et al. 2014 ) (Guo et al. 2007; Lewis et al. 2007; Li et al. 2007; Daniels et al. 2011) . The CD spectra of wild-type LRRK2 Roc-COR and [Y1699C] LRRK2 Roc-COR (Fig. 6d) indicate that the mutation induces minor perturbations to the secondary structure contents of LRRK2 tandem Roc-COR domain -a slight decrease on the a-helical structure contents and a slight increase in b-strand contents. We then examined how the secondary structure contents of LRRK2 Roc-COR and [Y1699C]LRRK2 Roc-COR are perturbed by increasing concentrations of guanidine hydrochloride. Figure 6 (e) shows that the Y1699C mutation did not significantly alter the sensitivity of the LRRK2 Roc-COR protein to structural perturbation by the denaturant, suggesting that the mutation does not significantly affect the stability of LRRK2 Roc-COR in solution.
To ascertain how the Y1699C mutation impacts the capacity of LRRK2 Roc-COR to bind guanine nucleotides, we compared the UV absorption spectra of the purified preparations of wild-type and [Y1699C]LRRK2 Roc-COR. Both spectra shown in Fig. 4 (a) exhibit significant absorption at 260 nm, suggesting tight binding of guanine nucleotide to (Fig. 5a) . Thus, the Y1699C mutation does not affect the ability of LRRK2 Roc-COR to tightly bind guanine nucleotide.
In contrast to the observations made by Daniels et al. (2011) that the Y1699C mutation almost completely abolished the GTPase activity of full-length LRRK2, we found that the mutation did not significantly affect the GTPase activity of LRRK2 Roc-COR (Fig. 6a) .
Taken together, our results shown in Figs 3-5 indicate that the PD-causative Y1699C mutation does not significantly alter the secondary structure contents and does not negatively impact the stability, GTP-binding capacity, and catalytic activity of LRRK2 Roc-COR tandem domain.
Discussion
Our results reveal that similar to the GADs of known structures (Gotthardt et al. 2008; Terheyden et al. 2015) , the C-terminal subdomain of COR domain of LRRK2 contains determinants mediating homodimerization. In spite of the structural similarities to GADs, LRRK2 Roc-COR exhibits enzymatic properties similar to those of Ras-like GTPases. Like Ras-like GTPases, LRRK2 Roc-COR binds Mg 2+ -GDP or Mg 2+ -GTP tightly at stoichiometry approaching 1 mol of Mg 2+ -GDP/GTP per mol of LRRK2 Roc-COR protein. Furthermore, similar to the Ras superfamily of GTPases, LRRK2 Roc-COR exhibits very low GTPase activity. Collectively, these results suggest that LRRK2 Roc-COR functions as a conventional Ras-like GTPase. Presumably, it requires the assistance of guanine nucleotide exchange factor (GEF(s)) and GTPase-activating protein (GAP(s)) to facilitate exchange of the guanine nucleotide tightly bound to its active site, and to enhance its catalysis of hydrolysis of GTP to GDP, respectively. We also generated the [Y1699C] LRRK2 Roc-COR and used it to demonstrate that the PDassociated Y1699C mutation does not significantly impact the secondary structure contents, stability, guanine nucleotide-binding capacity, and GTPase activity of the LRRK2 Roc-COR tandem domain in isolation. Of relevance, the 
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Residues #1314-1878 Expressed in Sf21 insect cells Y1699C mutation has no effect on activity Roc-COR/kinase (Rudi et al. 2015) 343 lM (WT) 541 lM (R1441C) -GDP/GTP bound to the active site was used for the kinetic analysis COR, C-terminal of Roc; Roc, Ras of complex; LRRK2, leucine-rich repeat kinase 2 same mutation reduces the rate of GTP hydrolysis catalyzed by full-length LRRK2 in vitro (Daniels et al. 2011) . Thus, the Y1699C mutation reduces the GTPase activity of LRRK2 only when the Roc-COR tandem domain is interacting with other functional domains. Since ours is the first study of the biochemical properties of the isolated LRRK2 Roc-COR tandem domain, our findings raise a number of questions related to the structure and regulation of LRRK2. These questions are discussed below.
Other evidence suggesting LRRK2 as a conventional Ras-like GTPase The two prokaryotic Roc-COR domains with known threedimensional structures form dimers and contain a conserved arginine that acts as an 'arginine finger' inserting into the active site of the neighboring Roc-COR monomer. This arginine residue is predicted to participate in catalysis in trans by stabilizing the transition-state intermediate of GTP hydrolysis. Mutations perturbing or abolishing dimerization cause significant reduction in GTPase activity (Gotthardt et al. 2008; Terheyden et al. 2015) . Besides, mutation of the putative 'arginine finger' residue either completely abolished or significantly reduced the catalytic activity of the C. tepidum and M. Barkeri Roco proteins, further confirming that dimerization and insertion of the arginine finger in trans to the Roc domain active site is critical for catalysis (Gotthardt et al. 2008; Terheyden et al. 2015) . Furthermore, the two prokaryotic Roco proteins bind GDP and GTP analogs with affinities (K D values in the lM range) much lower than those of the Ras-like GTPases (K D values in the nM range), suggesting that they do not require GEFs for the exchange of guanine nucleotides in their active sites. These results indicate that the two prokaryotic Roc-COR domains are GADs and the conserved arginine finger governs activation of their GTPase activity upon dimerization.
However, this arginine residue is missing in the Roc-COR domain of LRRK2 (Gotthardt et al. 2008) (Figure S1 ), prompting some researchers to suggest that LRRK2 is not a GAD (Liao et al. 2014) . In agreement with this prediction, Liao et al. (2014) demonstrated that LRRK2 Roc domain monomer is catalytically active, suggesting that dimerization is not necessary for the LRRK2 Roc domain GTPase activity. Recently, Deyaert et al. (2017) reported that C. tepidum Roc-COR, which is a bona fide GAD, undergoes a monomerdimer transition during GTP turnover in vitro. Unlike C tepidum Roc-COR, full-length LRRK2 forms dimers regardless of whether Mg 2+ -GDP or Mg 2+ -GTP analog resides in the Roc domain active site (Taymans et al. 2011) . Thus, these findings together further support that LRRK2 Roc-COR exhibits enzymatic properties similar to those of conventional Ras-like GTPases. In spite of such a similarity, LRRK2 Roc-COR is not a bona fide Ras-like GTPase because of its GAD-like ability to form homodimers via the C-terminal portion of its COR domain. For this reason, LRRK2 Roc-COR can be considered as a GAD-like GTPase exhibiting Ras-like GTPase enzymatic properties.
Is it possible to measure the rate of guanine nucleotide exchange of LRRK2 Roc-COR in vitro? The low K M value (22 nM) of the GTP hydrolysis reaction catalyzed by LRRK2 Roc-COR suggests that it binds GTP with a high affinity. However, K M is not a true measure of the affinity of LRRK2 Roc-COR for GTP. We therefore attempted to determine the dissociation constant of binding of radioactive GTP to LRRK2 Roc-COR as a direct measure of the affinity of LRRK2 Roc-COR for GTP. In brief, we incubated LRRK2 Roc-COR with [c- Since LRRK2 Roc-COR binds guanine nucleotides tightly, it likely requires a GEF to enhance the release of the tightly bound guanine nucleotide in exchange for the exogenous GTP or GDP. Direct measurement of the dissociation constants of LRRK2 Roc-COR for GTP and GDP using our method awaits the discovery of the LRRK2 GEF.
How does Y1699C mutation impact on the structure and function of LRRK2? Based upon the three-dimensional structure of the Roc-COR domain of C. tepidum Roc-COR protein, Gotthardt et al. (2008) mapped LRRK2 Tyr-1699 to the interface between the Roc and COR domains (Fig. 3a) . They then reported that mutation of Tyr-804 in C. tepidum Roc-COR, predicted as a homologous residue to human LRRK2 Tyr-1699 by sequence alignment, led to an eight-fold reduction in GTPase activity. Presumably, this mutation perturbs the Roc/COR interface and in turn adversely affects the catalytic activity (Gotthardt et al. 2008) . Based upon this result, Y1699C mutation is expected to perturb the LRRK2 Roc-COR structure and in turn reduce its catalytic activity. In contrast to this prediction, we found that Y1699C mutation did not significantly impact on the secondary structure contents, stability, and catalytic activity of LRRK2 Roc-COR (Fig. 6) .
Several groups of researchers investigated the impact of Y1699C mutation on the GTPase activity of recombinant full-length LRRK2. Unlike the lack of effect on the GTPase activity of LRRK2 Roc-COR protein (Fig. 6) , the mutation significantly reduced the GTPase activity of full-length LRRK2 (Xiong et al. 2010; Daniels et al. 2011) . The discrepancy of our results and the findings by Daniels et al. suggest that Y1699C mutation may indirectly alter the GTPase activity of the Roc domain by aberrant regulation of other functional domains in full-length LRRK2. Specifically, the Y1699C mutation leads to decreased phosphorylation of in the ankyrin region, as well as changes in autophosphorylation levels at Thr-1357 in the Roc domain and at Ser-1292 in the LRR region in cells. Additionally, the Y1699C mutation abolishes LRRK2 binding to 14-3-3 in cells (Nichols et al. 2010; Li et al. 2011; Doggett et al. 2012; Kamikawaji et al. 2013; Henry et al. 2015) . These changes may underpin the significant reduction in GTPase activity of full-length LRRK2 carrying the Y1699C mutation. Thus, rather than directly impacting the structure and stability of the LRRK2 Roc-COR domains, this mutation may affect the GTPase activity by perturbing interactions of the Roc-COR domains with other domains and/or autophosphorylation of LRRK2.
Implications of the differences in the enzymatic properties of the GTPase activity of LRRK2 Roc-COR and full-length LRRK2 Unlike LRRK2 Roc-COR, which binds guanine nucleotides with high affinities, full-length LRRK2 binds guanine nucleotides with a low affinity (0.36 lM) (Table 1) (Civiero et al. 2012) . Furthermore, full-length LRRK2, the truncated LRRK2 fragments consisting of the Roc-COR domain and the kinase domain with and without the LRR and WD40 domains all exhibited catalytic properties significantly different from those of LRRK2 Roc-COR. They hydrolyze GTP with much higher catalytic activity ( Figure S8 ) and with K m and k cat values much higher than those of LRRK2 Roc-COR (Table 1 ). These findings suggest that interactions of the Roc-COR domain with other functional domains of LRRK2 perturb the structure of Roc-COR to lower its affinity for guanine nucleotides, and in turn increase its GTPase activity. Further investigation is needed to unveil how other functional domains interact with the Roc-COR tandem domain in intact LRRK2 to regulate the affinities for guanine nucleotides and catalysis of GTP hydrolysis.
How can future studies of LRRK2 Roc-COR bridge the knowledge gaps in the field of LRRK2 research? The LRRK2 Roc-COR construct and its mutants described in this study open up opportunities for further studies to define the three-dimensional structure of the LRRK2 Roc-COR tandem domain and how the tandem domain interacts with other LRRK2 domains. Since LRRK2 Roc-COR exhibits a very low GTPase activity ( Fig. 6c and Figure S8 ), it potentially requires GAPs to enhance the rate of GTP hydrolysis. Xiong et al. (2012) discovered ADP-ribosylation factor GTPase-activating protein 1 (ArfGAP1) as a potential GAP of LRRK2 because it binds full-length LRRK2 and enhances LRRK2 GTPase activity by~2.5-fold. However, such a modest rate enhancement of LRRK2 GTPase activity by ArfGAP1 is much lower than that of Ras-GAPs, which can enhance Ras GTPase activity by~10 000-fold in vitro (Shutes and Der 2006) . These findings imply that GTPase activator activity of ArfGAP1 needs to be significantly upregulated for efficient regulation of LRRK2 GTPase activity. The recombinant LRRK2 Roc-COR complexed with [ 32 P] GTP described in this manuscript (Fig. 3) can be exploited for the design of in vitro assays to further characterize how the GTPase activator activity of ArfGAP1 is regulated.
Identifying the downstream effectors of LRRK2 GTPase domains is another frontier in the field of LRRK2 research. The LRRK2 Roc-COR construct can be used in future investigations as a bait to search for the downstream effectors of LRRK2 GTPase domain.
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